https://www.businesswire.com/news/home/20200108005300/en/
Enterprise Therapeutics Publishes Paper on Novel Therapeutic Approach for Treatment of All Cystic Fibrosis Patients
“TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis” published in American Journal of Respiratory and Critical Care Medicine
Paper demonstrates first in class TMEM16A chloride channel potentiators, to accelerate mucociliary clearance
Co-authored by researchers from University of Sussex, University of North Carolina and University of Miami
